The Medium-Chain Fatty Acid Receptor GPR84 Mediates Myeloid Cell Infiltration Promoting Steatohepatitis and Fibrosis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Medium-Chain Fatty Acid Receptor GPR84 Mediates Myeloid Cell Infiltration Promoting Steatohepatitis and Fibrosis
Authors
Keywords
-
Journal
Journal of Clinical Medicine
Volume 9, Issue 4, Pages 1140
Publisher
MDPI AG
Online
2020-04-17
DOI
10.3390/jcm9041140
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cenicriviroc Treatment for Adults with Nonalcoholic Steatohepatitis and Fibrosis: Final Analysis of the Phase 2b CENTAUR Study
- (2020) Vlad Ratziu et al. HEPATOLOGY
- Myeloid cells in liver and bone marrow acquire a functionally distinct inflammatory phenotype during obesity-related steatohepatitis
- (2019) Oliver Krenkel et al. GUT
- Single Cell RNA Sequencing Identifies Subsets of Hepatic Stellate Cells and Myofibroblastsin Liver Fibrosis
- (2019) Oliver Krenkel et al. Cells
- Cenicriviroc (CVC) for the Treatment of Liver Fibrosis in Adults With Nonalcoholic Steatohepatitis (NASH): AURORA Phase 3 Study Design
- (2019) Quentin M. Anstee et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- New drugs for NAFLD: lessons from basic models to the clinic
- (2019) Katharina C. Reimer et al. Hepatology International
- A Newly Discovered Antifibrotic Pathway Regulated by Two Fatty Acid Receptors
- (2018) Lyne Gagnon et al. AMERICAN JOURNAL OF PATHOLOGY
- Cenicriviroc for the treatment of non-alcoholic steatohepatitis and liver fibrosis
- (2018) Frank Tacke EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis
- (2018) Oliver Krenkel et al. HEPATOLOGY
- A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis
- (2018) Scott L. Friedman et al. HEPATOLOGY
- Macrophages contribute to the pathogenesis of sclerosing cholangitis in mice
- (2018) Maria Eugenia Guicciardi et al. JOURNAL OF HEPATOLOGY
- Mechanisms of NAFLD development and therapeutic strategies
- (2018) Scott L. Friedman et al. NATURE MEDICINE
- Embelin and its derivatives unravel the signaling, proinflammatory and antiatherogenic properties of GPR84 receptor
- (2018) Ibragim Gaidarov et al. PHARMACOLOGICAL RESEARCH
- Activation of the Immune-Metabolic Receptor GPR84 Enhances Inflammation and Phagocytosis in Macrophages
- (2018) Carlota Recio et al. Frontiers in Immunology
- Pharmacological inhibition of CCR2/5 signaling prevents and reverses alcohol-induced liver damage, steatosis and inflammation in mice
- (2018) Aditya Ambade et al. HEPATOLOGY
- Global Perspectives on Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis
- (2018) Zobair Younossi et al. HEPATOLOGY
- PBI-4050 Reduces Stellate Cell Activation and Liver Fibrosis through Modulation of Intracellular ATP Levels and the Liver Kinase B1/AMP-Activated Protein Kinase/Mammalian Target of Rapamycin Pathway
- (2018) Brigitte Grouix et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- An update on the recent advances in antifibrotic therapy
- (2018) Frank Tacke et al. Expert Review of Gastroenterology & Hepatology
- Dietary Lipids Differentially Shape NASH Progression and the Transcriptome of Kupffer Cells and Infiltrating Macrophages
- (2018) Brett McGettigan et al. HEPATOLOGY
- Adapted Immune Responses of Myeloid-Derived Cells in Fatty Liver Disease
- (2018) Jana Hundertmark et al. Frontiers in Immunology
- Effect of GPR84 deletion on obesity and diabetes development in mice fed long chain or medium chain fatty acid rich diets
- (2017) Eugene Du Toit et al. EUROPEAN JOURNAL OF NUTRITION
- Targeting hepatic macrophages to treat liver diseases
- (2017) Frank Tacke JOURNAL OF HEPATOLOGY
- Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD
- (2017) Hannes Hagström et al. JOURNAL OF HEPATOLOGY
- Differential impact of the dual CCR2/CCR5 inhibitor cenicriviroc on migration of monocyte and lymphocyte subsets in acute liver injury
- (2017) Tobias Puengel et al. PLoS One
- Effects of Long-Chain and Medium-Chain Fatty Acids on Apoptosis and Oxidative Stress in Human Liver Cells with Steatosis
- (2016) Baogui Wang et al. JOURNAL OF FOOD SCIENCE
- Keratin 23 is a stress-inducible marker of mouse and human ductular reaction in liver disease
- (2016) Nurdan Guldiken et al. JOURNAL OF HEPATOLOGY
- Immunology in the liver — from homeostasis to disease
- (2016) Felix Heymann et al. Nature Reviews Gastroenterology & Hepatology
- Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice
- (2013) Jean-Philippe Pradere et al. HEPATOLOGY
- Medium-chain Fatty Acid-sensing Receptor, GPR84, Is a Proinflammatory Receptor
- (2013) Masakatsu Suzuki et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Nonalcoholic steatohepatitis
- (2011) Jörn M. Schattenberg et al. CURRENT OPINION IN LIPIDOLOGY
- Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury
- (2011) Christer Baeck et al. GUT
- Enhancement of Muscle Mitochondrial Oxidative Capacity and Alterations in Insulin Action Are Lipid Species Dependent: Potent Tissue-Specific Effects of Medium-Chain Fatty Acids
- (2009) N. Turner et al. DIABETES
- Hepatic recruitment of the inflammatory Gr1+monocyte subset upon liver injury promotes hepatic fibrosis
- (2009) Karlin Raja Karlmark et al. HEPATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now